
Feature|Videos|July 16, 2025
The Ins and Outs of Value-Based Contracts: Timing, Evidence, and Risk Alignment
Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.
Advertisement
Episodes in this series

There is no shortcut to executing a value-based contract. In this episode, experts lay out what’s required to bring these agreements to life: evidence alignment, data compatibility, and mutual incentive. Payers want results, not just risk transference—and developers must understand and speak to payer business goals.
Key discussion topics include:
- Timeline and prerequisites for executing value-based contracts.
- Understanding what matters to payers vs. regulators.
- How to prototype contracting models for early feedback.
- The importance of strong head-to-head clinical data as the foundation.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The New Healthy Aging Imperative and What It Means for Pharma
2
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
3
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
4
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
5





